An oral version of Ozempic is in the works
Injectable weight-loss medication Wegovy and its counterpart Ozempic will likely be available in pill form in the future, researchers said Sunday at the American Diabetes Association Scientific Sessions conference.
According to one of the two studies presented, 50 milligrams of semaglutide, the active ingredient in both medications, ingested orally each day "is roughly as effective as weekly Wegovy shots in reducing weight in people who are overweight or obese," The New York Times reported, noting that Wegovy injections themselves contain 2.4 milligrams of semaglutide.
In the second study, roughly 1,600 Type 2 diabetics (the intended clientele for Ozempic) were divided into groups and given different daily doses of oral semaglutide. Those who received the two highest doses lost more weight than those who took the lowest dose, and also saw greater reductions in blood sugar, per the Times.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
"I suspect there are a lot of people that are not using these treatments because it requires an injection," said the American Diabetes Association's Dr. Robert Gabbay. "If you could say, 'Well, actually, it doesn't,' that's big."
Novo Nordisk, the company that manufactures both drugs and funded the trials, plans to file for approval with the Food and Drug Administration at some point in 2023, a spokesperson told NBC News. The company also already offers a lower-dose oral semaglutide called Rybelsus, which is approved for adults with Type 2 diabetes and is reportedly less effective than both Ozempic and Wegovy.
While the promise of an effective weight loss drug sounds enticing, both Wegovy and Ozempic are not without their side effects, which can include vomiting, nausea and diarrhea. And that's also without mentioning their possible broader societal impacts, such as the detrimental idealization of a certain body type.
"I am concerned about these medications being broadly used just to promote weight loss" and "how it contributes to our general diet culture, our cultural obsession with thinness," Dr. Scott Hagan, an assistant professor of medicine at the University of Washington, told the Times.
Likewise, Tigress Osborn, chair of the National Association to Advance Fat Acceptance, worries that a highly-effective weight loss pill will put pressure on those who are obese to use it, even if they don't want to. "There is no escape from the narrative that your body is wrong and it should change," he told The Associated Press.
Create an account with the same email registered to your subscription to unlock access.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Rishi Sunak's legacy: how the PM will be remembered
The Explainer 'Accidental prime minister' started with the 'weakest hand' of any British leader in the modern era
By Sorcha Bradley, The Week UK Published
-
State 'should fund weddings to combat loneliness', says report
Speed Read Married people are the least lonely, but report suggests the poorest are priced out
By Arion McNicoll, The Week UK Published
-
'Most see a guilty verdict for Trump'
Today's Newspapers A roundup of the headlines from the US front pages
By The Week Staff Published
-
Texas dairy worker gets bird flu from infected cow
Speed Read The virus has been spreading among cattle in Texas, Kansas, Michigan and New Mexico
By Peter Weber, The Week US Published
-
Dengue hits the Americas hard and early
Speed Read Puerto Rico has declared an epidemic as dengue cases surge
By Peter Weber, The Week US Published
-
US bans final type of asbestos
Speed Read Exposure to asbestos causes about 40,000 deaths in the U.S. each year
By Peter Weber, The Week US Published
-
Seattle Children's Hospital sues Texas over 'sham' demand for transgender medical records
Speed Read Texas Attorney General Ken Paxton subpoenaed records of any Texan who received gender-affirming care at the Washington hospital
By Peter Weber, The Week US Published
-
Afghanistan has a growing female suicide problem
Speed Read The Taliban has steadily whittled away women's and girls' rights in Afghanistan over the past 2 years, prompting a surge in depression and suicide
By Peter Weber, The Week US Published
-
US life expectancy rose in 2022 but not to pre-pandemic levels
Speed Read Life expectancy is slowly crawling back up
By Devika Rao, The Week US Published
-
Vallance diaries: Boris Johnson 'bamboozled' by Covid science
Speed Read Then PM struggled to get his head around key terms and stats, chief scientific advisor claims
By The Week UK Published
-
An increasing number of dog owners are 'vaccine hesitant' about rabies
Speed Read A new survey points to canine vaccine hesitancy
By Devika Rao, The Week US Published